Low levels of EPA and DHA omega-3s in red blood cell membranes may have a similar predictive power of early death to that of the well-established standard risk factors, such as smoking, says a new analysis.
After more than 25 years in the omega market, Polaris is looking to become a forerunner in the field of fish-free omega 3, with the launch of a microalgae oil promising at least 800 mg/g of DHA .
Supplements containing oil from black cumin (Nigella sativa) may help manage blood sugar and improve cardiometabolic measures in type-2 diabetics, says a new study.
Research looking into omega-3 fatty acids’ anti-inflammatory effects has been hailed as an ‘important contribution’ for patients with depression to receive targeted mechanistically based treatment.
Royal DSM has entered into a broad commercial partnership with Colorado-based cannabinoid company Mile High Labs (MHL) for next generation science-backed cannabinoid solutions.
Fish oil supplements enriched with EPA (eicosapentaenoic acid), but not DHA (docosahexaenoic acid), may boost accuracy and speed of cognitive function, compared to placebo, says a new RCT from Europe.
Tumour cells poison themselves when consuming an Omega-3 fatty acid due to an inability to store it correctly, a study claims, which proposes this mechanism to explain the fatty acid’s cancer-fighting abilities.
Natures Crops International has announced its omega-3 rich Ahiflower plant is now registered and protected under the European and US Plant Variety Protection (PVP) programs.
Fish-derived supplements, particularly those containing collagen, have potential beneficial properties for managing type 2 diabetes and metabolic syndrome via modulation of the gut microbiome, according to a new study in mice.
Greenland has long been a source of mystery and wonder for the Danish people. One medieval mystery has never been solved, while a more recent one, the story of omega-3 fatty acids, continues to play out in a thriving industry that has fundamentally impacted...
Sam Wiley, CEO of Wiley’s Finest line of omega-3 products, said he’s confident in the course of the category and in the future of the brand as he steps down from a leadership position at the family owned company.
New research has found that over 68% of adults and 95% of children in the United States do not consume enough omega-3s to meet nutritional needs based on the US Dietary Guidelines.
Progress Biotech has received EU approval for the use of its high docosahexaenoic acid (DHA) algal oil in infant formula in a move that meets demand for sustainable vegan-based ingredients along with DHA’s known health benefits.
